1.70
price up icon3.03%   0.05
after-market Handel nachbörslich: 1.69 -0.01 -0.59%
loading
Schlusskurs vom Vortag:
$1.65
Offen:
$1.6301
24-Stunden-Volumen:
62,557
Relative Volume:
0.23
Marktkapitalisierung:
$270.74M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-7.5656
EPS:
-0.2247
Netto-Cashflow:
-
1W Leistung:
+8.28%
1M Leistung:
-8.60%
6M Leistung:
-23.08%
1J Leistung:
-9.57%
1-Tages-Spanne:
Value
$1.63
$1.70
1-Wochen-Bereich:
Value
$1.5597
$1.71
52-Wochen-Spanne:
Value
$1.32
$2.72

Immutep Limited Adr Stock (IMMP) Company Profile

Name
Firmenname
Immutep Limited Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
44
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-24
Name
Neueste SEC-Einreichungen
Name
IMMP's Discussions on Twitter

Vergleichen Sie IMMP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IMMP
Immutep Limited Adr
1.70 270.74M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-17 Eingeleitet CapitalOne Overweight
2023-08-03 Eingeleitet Robert W. Baird Outperform
2021-08-03 Eingeleitet Ladenburg Thalmann Buy
2021-07-16 Fortgesetzt Maxim Group Buy
2018-09-28 Eingeleitet B. Riley FBR Buy
2018-02-15 Bestätigt Maxim Group Buy
Alle ansehen

Immutep Limited Adr Aktie (IMMP) Neueste Nachrichten

pulisher
Jun 15, 2025

Millennium Management LLC Sells 19,242 Shares of Immutep Limited (NASDAQ:IMMP) - Defense World

Jun 15, 2025
pulisher
Jun 08, 2025

Jane Street Group LLC Has $98,000 Position in Immutep Limited (NASDAQ:IMMP) - Defense World

Jun 08, 2025
pulisher
Jun 01, 2025

Immutep Ltd Highlights Immune System Innovations at Healthcare Conference - TipRanks

Jun 01, 2025
pulisher
May 08, 2025

Market Highlights: Immutep Limited ADR (IMMP) Ends on a Low Note at 1.93 - DWinneX

May 08, 2025
pulisher
May 06, 2025

Immutep stock soars on promising trial results - Investing.com Australia

May 06, 2025
pulisher
May 05, 2025

Immutep stock soars on promising trial results By Investing.com - Investing.com Nigeria

May 05, 2025
pulisher
Apr 29, 2025

Immutep Quarterly Activities Report Q3 FY25 - The Manila Times

Apr 29, 2025
pulisher
Apr 02, 2025

Immutep to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.

Apr 02, 2025
pulisher
Mar 24, 2025

Immutep Limited (ASX:IMM) Initiates Phase III Trial for Non-Small Cell Lung Cancer - thecapitalclub.com.au

Mar 24, 2025
pulisher
Feb 11, 2025

Is Immutep Limited (IMMP) the Best Long Term ASX Stock to Buy Now? - AInvest

Feb 11, 2025
pulisher
Jan 14, 2025

Immutep Limited (NASDAQ:IMMP) Shares Sold by Jane Street Group LLC - Defense World

Jan 14, 2025
pulisher
Dec 18, 2024

Verition Fund Management LLC Has $57,000 Stock Position in Immutep Limited (NASDAQ:IMMP) - Defense World

Dec 18, 2024
pulisher
Dec 17, 2024

Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - GlobeNewswire

Dec 17, 2024
pulisher
Oct 29, 2024

Immutep Quarterly Activities Report Q1 FY25 - Yahoo Finance

Oct 29, 2024
pulisher
Oct 17, 2024

Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial - Yahoo Finance

Oct 17, 2024
pulisher
Jun 27, 2024

Baird cuts Immutep stock target on phase 2b trial results, retains Outperform - Investing.com

Jun 27, 2024
pulisher
Apr 18, 2024

Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761 - GlobeNewswire

Apr 18, 2024
pulisher
Feb 05, 2024

10 Best Australian Stocks To Buy - Yahoo Finance

Feb 05, 2024
pulisher
Nov 27, 2023

Immutep LimitedADR (IMMP) Price Target Increased by 5.10% to 2.59 - Nasdaq

Nov 27, 2023
pulisher
Mar 30, 2023

Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung Cancer - GlobeNewswire

Mar 30, 2023
pulisher
Nov 03, 2022

Check Up: These 4 ASX healthcare stocks come with Strong Buy recommendations - Stockhead

Nov 03, 2022
pulisher
Dec 16, 2021

ICE Announces Annual Reconstitution Changes in the ICE Biotechnology Index - Business Wire

Dec 16, 2021
pulisher
Apr 08, 2021

FDA Grants Fast Track Designation to 1L Eftilagimod Alpha for Recurrent or Metastatic HNSCC - Targeted Oncology

Apr 08, 2021
pulisher
Dec 30, 2020

Best Penny Stocks To Buy For 2021? 5 Biotech Stocks To Watch - Penny Stocks

Dec 30, 2020
pulisher
Sep 06, 2020

IMMPImmutep Latest Stock News & Market Updates - Stock Titan

Sep 06, 2020
pulisher
Apr 18, 2019

Immutep Ltd (IMMP) Stock Price, Trades & News - GuruFocus

Apr 18, 2019
pulisher
Dec 10, 2017

A Full List of Australia ADRs - Investing.com Australia

Dec 10, 2017
pulisher
Dec 05, 2017

Prima BioMed (IMMP) Stock Price, News & Analysis - MarketBeat

Dec 05, 2017
pulisher
May 14, 2017

Prima BioMed Share Price | NASDAQ IMMP Stock - Investing.com Australia

May 14, 2017
pulisher
May 13, 2017

Prima BioMed Stock Price Today | NASDAQ: IMMP Live - Investing.com

May 13, 2017
pulisher
May 13, 2017

Prima BioMed Stock Price Today | NASDAQ IMMP - Investing.com Canada

May 13, 2017
pulisher
Jul 27, 2011

ADVFN | Live Stock, Options & Crypto Market Data, Trading Tools & Community - advfn.com

Jul 27, 2011

Finanzdaten der Immutep Limited Adr-Aktie (IMMP)

Es liegen keine Finanzdaten für Immutep Limited Adr (IMMP) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):